|
US3378587A
(en)
|
1963-03-14 |
1968-04-16 |
Du Pont |
3, 3'-diaminomethyl-1, 1'-biadamantane
|
|
NL127995C
(enExample)
|
1963-12-20 |
|
Geigy Ag J R |
|
|
US3341538A
(en)
*
|
1965-06-18 |
1967-09-12 |
Geigy Chem Corp |
Certain 2, 6-methano-3-benzazocines
|
|
DE2108954A1
(en)
|
1971-02-25 |
1972-09-07 |
Boehringer Sohn Ingelheim |
2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents
|
|
DE1801556A1
(de)
|
1968-10-05 |
1970-05-21 |
Huels Chemische Werke Ag |
Verfahren zur Herstellung von substituierten Hexahydropyrimidinonen-(2)
|
|
GB1304175A
(enExample)
|
1969-03-31 |
1973-01-24 |
|
|
|
DE2105743C3
(de)
|
1971-02-08 |
1979-11-29 |
Boehringer Sohn Ingelheim |
2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
|
|
US3681349A
(en)
*
|
1970-03-05 |
1972-08-01 |
Morton Norwich Products Inc |
1-(substituted benzyl) tetrahydro-2-(1h) pyrimidones
|
|
US4043927A
(en)
|
1972-03-07 |
1977-08-23 |
Sun Ventures, Inc. |
Friction or tractive drive containing ethers of adamantanes
|
|
DE2229695A1
(de)
|
1972-06-19 |
1974-01-31 |
Boehringer Sohn Ingelheim |
2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
|
|
DE2338369A1
(de)
|
1973-07-26 |
1975-02-13 |
Schering Ag |
Mikrobiologische hydroxylierung von 2,6-methano-3-benzazocinen
|
|
SU511005A3
(ru)
|
1973-10-27 |
1976-04-15 |
К.Х.Берингер Зон., (Фирма) |
Способ получени (метоксиметилфурилметил)6,7-бензоморфанов или морфинанов
|
|
US4009171A
(en)
|
1974-02-21 |
1977-02-22 |
Sterling Drug Inc. |
N-acylated-11-oxygenated-2,6-methano-3-benzazocine intermediates
|
|
DE2411382C3
(de)
|
1974-03-09 |
1979-09-06 |
C.H. Boehringer Sohn, 6507 Ingelheim |
2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
|
|
US4136162A
(en)
*
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
US4136145A
(en)
*
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
DE2437610A1
(de)
|
1974-08-05 |
1976-02-26 |
Boehringer Sohn Ingelheim |
Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
|
|
GB1513961A
(en)
|
1975-02-25 |
1978-06-14 |
Acf Chemiefarma Nv |
6,7-benzomorphans method for their preparation and intermediates
|
|
US4108857A
(en)
|
1975-08-18 |
1978-08-22 |
Sterling Drug Inc. |
Imidazolylmethyl methanobenzazocines
|
|
DE2828039A1
(de)
|
1978-06-26 |
1980-01-10 |
Boehringer Sohn Ingelheim |
2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
|
|
CA2023492A1
(en)
|
1989-08-31 |
1991-03-01 |
Barry Clifford Lange |
Herbicidal glutarimides
|
|
US5393735A
(en)
|
1990-08-09 |
1995-02-28 |
Rohm And Haas Company |
Herbicidal glutarimides
|
|
US5098916A
(en)
|
1990-03-29 |
1992-03-24 |
G. D. Searle & Co. |
Propanobicyclic amine derivatives for cns disorders
|
|
EP0454444A1
(en)
|
1990-04-24 |
1991-10-30 |
Nissan Chemical Industries Ltd. |
Glutarimide derivatives and herbicides
|
|
US5215992A
(en)
|
1990-04-30 |
1993-06-01 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for CNS disorders
|
|
US5089506A
(en)
|
1990-04-30 |
1992-02-18 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for cns disorders
|
|
CA2049244A1
(en)
|
1990-08-16 |
1992-02-17 |
Steven H. Christiansen |
Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom
|
|
US5432175A
(en)
*
|
1990-10-10 |
1995-07-11 |
Schering Corporation |
Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
|
|
DE4119611A1
(de)
*
|
1991-06-14 |
1992-12-17 |
Bayer Ag |
Mittel zur bekaempfung von schaedlingen auf basis substituierter oxazolidinone, neue substituierte oxazolidinone, deren herstellung und verwendung
|
|
US5610294A
(en)
*
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
HU220601B1
(hu)
|
1992-04-30 |
2002-03-28 |
Taiho Pharmaceutical Co. Ltd. |
Fenoxi-alkil-oxazolidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
|
JPH0753721B2
(ja)
|
1992-09-11 |
1995-06-07 |
工業技術院長 |
環状ウレタン化合物の製造法
|
|
GB9225377D0
(en)
|
1992-12-04 |
1993-01-27 |
Ici Plc |
Herbicides
|
|
HU224548B1
(hu)
|
1993-04-07 |
2005-10-28 |
Taiho Pharmaceutical Co. Ltd. |
Tiazolidinszármazékok és ezeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
|
|
TW280812B
(enExample)
|
1993-07-02 |
1996-07-11 |
Bayer Ag |
|
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
|
JPH07157681A
(ja)
|
1993-12-08 |
1995-06-20 |
Konica Corp |
有機顔料の製造方法及び有機顔料を含有する電子写真感光体
|
|
JPH07309850A
(ja)
*
|
1994-05-16 |
1995-11-28 |
Canon Inc |
光学活性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、表示装置
|
|
DE19500118A1
(de)
|
1994-05-18 |
1995-11-23 |
Bayer Ag |
Substituierte Diazacyclohexandi(thi)one
|
|
FR2729954B1
(fr)
|
1995-01-30 |
1997-08-01 |
Sanofi Sa |
Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
|
|
US5780466A
(en)
|
1995-01-30 |
1998-07-14 |
Sanofi |
Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
|
|
GB9510459D0
(en)
|
1995-05-24 |
1995-07-19 |
Zeneca Ltd |
Bicyclic amines
|
|
US5776959A
(en)
|
1995-06-05 |
1998-07-07 |
Washington University |
Anticonvulsant and anxiolytic lactam and thiolactam derivatives
|
|
GB9517622D0
(en)
|
1995-08-29 |
1995-11-01 |
Univ Edinburgh |
Regulation of intracellular glucocorticoid concentrations
|
|
JPH09151179A
(ja)
*
|
1995-11-30 |
1997-06-10 |
Canon Inc |
光学活性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた液晶装置及び表示方法
|
|
WO1998004534A1
(en)
*
|
1996-07-31 |
1998-02-05 |
Nikken Chemicals Co., Ltd. |
6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
US6794390B2
(en)
|
1996-08-02 |
2004-09-21 |
Cv Therapeutics, Inc. |
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
|
|
GB9623944D0
(en)
|
1996-11-15 |
1997-01-08 |
Zeneca Ltd |
Bicyclic amine derivatives
|
|
US6159990A
(en)
*
|
1997-06-18 |
2000-12-12 |
Synaptic Pharmaceutical Corporation |
Oxazolidinones as α1A receptor antagonists
|
|
US6089506A
(en)
*
|
1997-06-30 |
2000-07-18 |
Scheffel; Bernd W. |
Thermal center flight indicator for gliders
|
|
CZ20001613A3
(cs)
*
|
1997-11-07 |
2001-12-12 |
Pharmacia & Upjohn Company |
Způsob výroby oxazolidinonů
|
|
US5936124A
(en)
|
1998-06-22 |
1999-08-10 |
Sepacor Inc. |
Fluoxetine process from benzoylpropionic acid
|
|
US7410995B1
(en)
|
1998-08-14 |
2008-08-12 |
Gpi Nil Holdings Inc. |
N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
|
|
DE19918725A1
(de)
|
1999-04-24 |
2000-10-26 |
Bayer Ag |
Substituierte N-Cyano-sulfonsäureanilide
|
|
DE19929348A1
(de)
|
1999-06-26 |
2000-12-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten
|
|
US7256005B2
(en)
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
JP2003507424A
(ja)
|
1999-08-26 |
2003-02-25 |
ブリストル−マイヤーズ スクイブ カンパニー |
Npyアンタゴニスト:スピロイソキノリノン誘導体
|
|
US6436928B1
(en)
|
1999-12-17 |
2002-08-20 |
Schering Corporation |
Selective neurokinin antagonists
|
|
ES2258485T3
(es)
|
1999-12-17 |
2006-09-01 |
Schering Corporation |
Antagonistas selectivos de neuroquinina.
|
|
GB0003397D0
(en)
|
2000-02-14 |
2000-04-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE10034623A1
(de)
|
2000-07-17 |
2002-01-31 |
Bayer Ag |
Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
|
|
DE10034800A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Benzostickstoffheterocyclen
|
|
DE10034803A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Sulfonsäureanilide
|
|
DE10035928A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035927A1
(de)
*
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035908A1
(de)
*
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
US6559163B2
(en)
|
2000-08-16 |
2003-05-06 |
Neurogen Corporation |
2,4-substituted quinoline derivatives
|
|
US7294637B2
(en)
*
|
2000-09-11 |
2007-11-13 |
Sepracor, Inc. |
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
|
|
US7517892B2
(en)
|
2000-09-11 |
2009-04-14 |
Sepracor Inc. |
Ligands for monoamine receptors and transporters, and methods of use thereof
|
|
JP2002179572A
(ja)
|
2000-10-06 |
2002-06-26 |
Nikken Chem Co Ltd |
アレルギー性眼疾患治療剤
|
|
US6841671B2
(en)
|
2000-10-26 |
2005-01-11 |
Pfizer Inc. |
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
US20030143668A1
(en)
|
2001-06-18 |
2003-07-31 |
National Institute Of Advanced Industrial |
Guanosine triphosphate-binding protein coupled receptors
|
|
JP3873115B2
(ja)
|
2001-09-25 |
2007-01-24 |
独立行政法人産業技術総合研究所 |
環状ウレタン製造方法
|
|
MXPA04003474A
(es)
*
|
2001-10-15 |
2004-07-30 |
Schering Corp |
Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pirimidinas como antagonistas del receptor de adenosina a2a.
|
|
WO2003043988A1
(en)
|
2001-11-22 |
2003-05-30 |
Ono Pharmaceutical Co., Ltd. |
Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
|
|
JP2003300884A
(ja)
|
2002-04-08 |
2003-10-21 |
Nikken Chem Co Ltd |
TNF−α産生阻害剤
|
|
AU2003219410A1
(en)
|
2002-04-26 |
2003-11-10 |
Pfizer Products Inc. |
Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
|
|
WO2003091258A1
(en)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
AU2003229953A1
(en)
|
2002-04-30 |
2003-11-17 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
CN103405431B
(zh)
|
2002-05-17 |
2016-04-13 |
台湾J药品有限公司 |
阿片和阿片样化合物及其用途
|
|
JP4592077B2
(ja)
|
2002-07-03 |
2010-12-01 |
シェーリング コーポレイション |
嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−1(nk−1)アンタゴニストとしての1−アミド−4−フェニル−4−ベンジルオキシメチル−ピペリジン誘導体および関連化合物
|
|
AU2003249812A1
(en)
|
2002-07-18 |
2004-02-09 |
Queen's University At Kingston |
Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
|
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
|
TWI347946B
(en)
|
2002-10-11 |
2011-09-01 |
Otsuka Pharma Co Ltd |
2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
|
|
WO2004046137A1
(en)
|
2002-11-21 |
2004-06-03 |
Vicore Pharma Ab |
New tricyclic angiotensin ii agonists
|
|
GB0228410D0
(en)
*
|
2002-12-05 |
2003-01-08 |
Glaxo Group Ltd |
Novel Compounds
|
|
EP1581520A4
(en)
|
2002-12-13 |
2006-08-23 |
Smithkline Beecham Corp |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
ATE474577T1
(de)
*
|
2003-03-26 |
2010-08-15 |
Merck Sharp & Dohme |
Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
|
|
JP2006522746A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
置換されたアミドの薬学的使用
|
|
US7700583B2
(en)
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
DE10358004A1
(de)
|
2003-12-11 |
2005-07-14 |
Abbott Gmbh & Co. Kg |
Ketolactam-Verbindungen und ihre Verwendung
|
|
US7186844B2
(en)
|
2004-01-13 |
2007-03-06 |
Mitsubishi Gas Chemical Co., Inc. |
Method for producing cyclic carbamate ester
|
|
JP4324669B2
(ja)
|
2004-01-21 |
2009-09-02 |
独立行政法人産業技術総合研究所 |
環状ウレタンの製造方法
|
|
JP2005239670A
(ja)
|
2004-02-27 |
2005-09-08 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
JP2007528396A
(ja)
|
2004-03-09 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害薬
|
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
JP2005272321A
(ja)
|
2004-03-23 |
2005-10-06 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
EP1747199B1
(en)
|
2004-05-07 |
2014-09-17 |
Janssen Pharmaceutica NV |
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
GB0411404D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxo Group Ltd |
Novel compounds
|
|
ES2318503T3
(es)
|
2004-05-24 |
2009-05-01 |
Amgen Inc. |
Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
|
|
CA2571258A1
(en)
|
2004-06-24 |
2006-01-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
GB0414438D0
(en)
|
2004-06-28 |
2004-07-28 |
Syngenta Participations Ag |
Chemical compounds
|
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
EP1621535A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621539A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621536A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
CA2575808A1
(en)
|
2004-08-02 |
2006-02-16 |
Osi Pharmaceuticals, Inc. |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
|
WO2006036395A2
(en)
|
2004-08-23 |
2006-04-06 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
WO2006024627A2
(en)
*
|
2004-08-30 |
2006-03-09 |
Janssen Pharmaceutica N.V. |
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
AU2005285035B2
(en)
|
2004-09-10 |
2012-03-22 |
Janssen Pharmaceutica N.V. |
Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
|
|
GEP20125565B
(en)
|
2004-11-10 |
2012-07-10 |
Incyte Corp |
Lactam compounds and their pharmaceutical use
|
|
US20060167044A1
(en)
|
2004-12-20 |
2006-07-27 |
Arnaiz Damian O |
Piperidine derivatives and their use as anti-inflammatory agents
|
|
CA2591940A1
(en)
|
2004-12-23 |
2006-06-29 |
Chiesi Farmaceutici S.P.A. |
Azole derivatives with antimuscarinic activity
|
|
WO2006071819A1
(en)
|
2004-12-28 |
2006-07-06 |
Exelixis, Inc. |
[1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
|
CA2595205A1
(en)
|
2005-01-19 |
2006-07-27 |
Neurogen Corporation |
Heteroaryl substituted piperazinyl-pyridine analogues
|
|
CN101203509B
(zh)
*
|
2005-02-16 |
2013-05-08 |
默沙东公司 |
具有cxcr3拮抗剂活性的胺-连接的吡啶基和苯基取代的哌嗪-哌啶
|
|
BRPI0607946A2
(pt)
*
|
2005-02-16 |
2009-10-20 |
Schering Corp |
piperazina-piperidinas substituìdas por pirazinila com atividade de antagonista cxcr3
|
|
WO2006088837A2
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Heterocyclic substituted piperazines with cxcr3 antagonist activity
|
|
US7776862B2
(en)
*
|
2005-02-16 |
2010-08-17 |
Schering Corporation |
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
|
|
CA2598459A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
|
|
WO2006088836A2
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Piperazine-piperidines with cxcr3 antagonist activity
|
|
KR100890886B1
(ko)
|
2005-02-24 |
2009-03-31 |
니혼노야쿠가부시키가이샤 |
신규 할로알킬설폰아닐리드 유도체, 제초제 및 이의 이용방법
|
|
EP1864971A4
(en)
|
2005-03-31 |
2010-02-10 |
Takeda Pharmaceutical |
PROPHYLACTIC / THERAPEUTIC AGENT AGAINST DIABETES
|
|
WO2006109056A1
(en)
|
2005-04-12 |
2006-10-19 |
Vicore Pharma Ab |
New tricyclic angiotensin ii agonists
|
|
WO2007008529A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc |
Celullar cholesterol absorption modifiers
|
|
CA2618474A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Boehringer Ingelheim International Gmbh |
Compounds for treating alzheimer's disease
|
|
EP1924265A4
(en)
|
2005-08-16 |
2010-06-02 |
Genzyme Corp |
COMPOUNDS BINDING TO CHEMOKINE RECEPTORS
|
|
ES2382163T3
(es)
*
|
2005-10-11 |
2012-06-05 |
Schering Corporation |
Compuestos heterocíclicos sustituidos con actividad antagonista de CXCR3
|
|
TW200804274A
(en)
|
2005-10-27 |
2008-01-16 |
Ucb Sa |
Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
|
|
JP2007140188A
(ja)
|
2005-11-18 |
2007-06-07 |
Fujifilm Corp |
ポジ型感光性組成物及びそれを用いたパターン形成方法
|
|
WO2007061661A2
(en)
|
2005-11-22 |
2007-05-31 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
NZ568446A
(en)
*
|
2005-12-05 |
2011-12-22 |
Incyte Corp |
Lactam compounds and methods of using the same as modulators of 11-beta hydroxyl steroid dehydrogenase 1
|
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
|
WO2007076055A2
(en)
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
DE102005062990A1
(de)
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
|
CA2635083C
(en)
|
2005-12-30 |
2014-10-28 |
Merck & Co., Inc. |
Oxazolidinone derivatives as cetp inhibitors
|
|
KR20140107671A
(ko)
|
2005-12-30 |
2014-09-04 |
머크 샤프 앤드 돔 코포레이션 |
Cetp 억제제로서 유용한 1,3-옥사졸리딘-2-온 유도체
|
|
US8865707B2
(en)
*
|
2005-12-30 |
2014-10-21 |
Merck Sharp & Dohme Corp. |
Cholesteryl ester transfer protein inhibitors
|
|
WO2007081571A2
(en)
|
2005-12-30 |
2007-07-19 |
Merck & Co., Inc. |
Cetp inhibitors
|
|
US7998959B2
(en)
|
2006-01-12 |
2011-08-16 |
Incyte Corporation |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
|
CA2643163C
(en)
|
2006-02-27 |
2020-01-28 |
Bayer Healthcare Llc |
Temperature-adjusted analyte determination for biosensor systems
|
|
US20070213311A1
(en)
|
2006-03-02 |
2007-09-13 |
Yun-Long Li |
Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
WO2007109456A2
(en)
|
2006-03-16 |
2007-09-27 |
Pharmacopeia, Inc. |
Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
JP2007254409A
(ja)
|
2006-03-24 |
2007-10-04 |
Taisho Pharmaceut Co Ltd |
イミダゾリジノン誘導体
|
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
CN101426769A
(zh)
|
2006-04-20 |
2009-05-06 |
杜邦公司 |
五元杂环无脊椎害虫防治剂
|
|
BRPI0710273A2
(pt)
*
|
2006-04-21 |
2011-08-09 |
Lilly Co Eli |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, intermediário
|
|
AU2007240458B2
(en)
|
2006-04-21 |
2012-03-15 |
Eli Lilly And Company |
Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
|
|
DK2035379T3
(da)
|
2006-04-25 |
2010-09-06 |
Lilly Co Eli |
Inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
|
|
US8178005B2
(en)
|
2006-06-20 |
2012-05-15 |
Chemtura Corporation |
Liquid phosphite compositions having different alkyl groups
|
|
PE20080344A1
(es)
|
2006-06-27 |
2008-06-09 |
Sanofi Aventis |
Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1
|
|
WO2008012622A2
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
US7618989B2
(en)
|
2006-08-15 |
2009-11-17 |
Wyeth |
Tricyclic oxazolidone derivatives useful as PR modulators
|
|
US7649007B2
(en)
|
2006-08-15 |
2010-01-19 |
Wyeth Llc |
Oxazolidine derivatives as PR modulators
|
|
WO2008021337A1
(en)
|
2006-08-15 |
2008-02-21 |
Wyeth |
Oxazinan-2-one derivatives useful as pr modulators
|
|
EP2064187A2
(en)
|
2006-08-25 |
2009-06-03 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
WO2008031227A1
(en)
|
2006-09-14 |
2008-03-20 |
Neuromed Pharmaceuticals Ltd. |
Diaryl piperidine compounds as calcium channel blockers
|
|
WO2008036715A1
(en)
|
2006-09-22 |
2008-03-27 |
Novartis Ag |
Heterocyclic organic compounds
|
|
DE102007005799B4
(de)
|
2006-10-18 |
2018-01-25 |
Heinz-Jürgen Mühlen |
Verfahren zur Erzeugung eines wasserstoffreichen Produktgases
|
|
TW200829171A
(en)
*
|
2006-11-17 |
2008-07-16 |
Nihon Nohyaku Co Ltd |
Haloalkyl sulfonanilide derivatives or salts thereof, herbicide using it as effective constituent and use-method thereof
|
|
EP1935420A1
(en)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
|
EP2125750B1
(en)
*
|
2007-02-26 |
2014-05-21 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
JP2010522174A
(ja)
|
2007-03-23 |
2010-07-01 |
シェーリング コーポレイション |
Hcvns3−プロテアーゼ阻害剤としてのヒドラジド−ペプチド
|
|
AU2008233930A1
(en)
|
2007-03-29 |
2008-10-09 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
JP5470557B2
(ja)
|
2007-07-26 |
2014-04-16 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤の合成
|
|
WO2009020140A1
(ja)
|
2007-08-06 |
2009-02-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
アダマンチルウレア誘導体
|
|
JP2009110842A
(ja)
|
2007-10-31 |
2009-05-21 |
Sumitomo Chemical Co Ltd |
ボタンスイッチ被覆用積層樹脂体
|
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
AR069545A1
(es)
|
2007-11-16 |
2010-02-03 |
Boehringer Ingelheim Pharma |
Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
|
|
US8440658B2
(en)
|
2007-12-11 |
2013-05-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
KR101460359B1
(ko)
|
2007-12-13 |
2014-11-10 |
삼성전자주식회사 |
이동통신 시스템에서의 핸드오버 방법 및 장치
|
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
JP5490020B2
(ja)
|
2008-01-24 |
2014-05-14 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
|
|
WO2009102428A2
(en)
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
|
|
WO2009100872A1
(en)
|
2008-02-12 |
2009-08-20 |
Boehringer Ingelheim International Gmbh |
Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
|
CA2715290A1
(en)
|
2008-02-15 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
JP5108557B2
(ja)
|
2008-02-27 |
2012-12-26 |
東京エレクトロン株式会社 |
ロードロック装置および基板冷却方法
|
|
WO2009108332A1
(en)
|
2008-02-27 |
2009-09-03 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
|
EP2274287B1
(en)
|
2008-03-18 |
2016-03-09 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
TW200944526A
(en)
|
2008-04-22 |
2009-11-01 |
Vitae Pharmaceuticals Inc |
Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
JP5301563B2
(ja)
|
2008-05-01 |
2013-09-25 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
|
TW201004945A
(en)
|
2008-05-01 |
2010-02-01 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
EP2291373B1
(en)
|
2008-05-01 |
2013-09-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8592410B2
(en)
|
2008-05-01 |
2013-11-26 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
|
|
WO2009138386A2
(en)
|
2008-05-13 |
2009-11-19 |
Boehringer Ingelheim International Gmbh |
Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
|
|
US20110224242A1
(en)
|
2008-07-23 |
2011-09-15 |
Bioalliance Pharma |
Styrlyquinolines, their process of preparation and their therapeutic uses
|
|
CA2729998A1
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2010127237A2
(en)
|
2009-04-30 |
2010-11-04 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
JP5379160B2
(ja)
|
2008-07-25 |
2013-12-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
|
CN102105454A
(zh)
|
2008-07-25 |
2011-06-22 |
贝林格尔.英格海姆国际有限公司 |
合成1型11β-羟基类固醇脱氢酶的抑制剂
|
|
JP5846909B2
(ja)
|
2008-07-25 |
2016-01-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
1,1’−ジアダマンチルカルボン酸、このような化合物を含有する医薬及びその使用
|
|
CA2735204C
(en)
|
2008-08-25 |
2017-06-20 |
Boehringer Ingelheim International Gmbh |
Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
|
|
TW201022266A
(en)
|
2008-10-23 |
2010-06-16 |
Boehringer Ingelheim Int |
Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
|
|
US8637505B2
(en)
|
2009-02-04 |
2014-01-28 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CA2750517A1
(en)
|
2009-02-04 |
2010-08-12 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8563583B2
(en)
|
2009-03-09 |
2013-10-22 |
Bristol-Myers Squibb Company |
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
|
|
MA33216B1
(fr)
|
2009-04-30 |
2012-04-02 |
Boehringer Ingelheim Int |
Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
|
|
EP2438049B1
(en)
|
2009-06-02 |
2014-05-14 |
Boehringer Ingelheim International GmbH |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
AR076936A1
(es)
|
2009-06-02 |
2011-07-20 |
Vitae Pharmaceuticals Inc |
Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1
|
|
EP2440537A1
(en)
|
2009-06-11 |
2012-04-18 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
|
|
EP2448928B1
(en)
|
2009-07-01 |
2014-08-13 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2011031979A1
(en)
|
2009-09-11 |
2011-03-17 |
Cylene Pharmaceuticals Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
|
JP5750449B2
(ja)
|
2009-11-05 |
2015-07-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規キラルリンリガンド
|
|
TWI531571B
(zh)
|
2009-11-06 |
2016-05-01 |
維它藥物公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
|
|
EP2582698B1
(en)
|
2010-06-16 |
2016-09-14 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
|
EP2585444B1
(en)
|
2010-06-25 |
2014-10-22 |
Boehringer Ingelheim International GmbH |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
|
WO2012059416A1
(en)
|
2010-11-02 |
2012-05-10 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations for the treatment of metabolic disorders
|